Search Results

There are 2893 results for: content related to: Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

  1. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6

    Clinical & Experimental Allergy

    Volume 45, Issue 5, May 2015, Pages: 928–939, L. Orivuori, K. Mustonen, M. C. de Goffau, S. Hakala, M. Paasela, C. Roduit, J.-C. Dalphin, J. Genuneit, R. Lauener, J. Riedler, J. Weber, E. von Mutius, J. Pekkanen, H. J. M. Harmsen, O. Vaarala and the PASTURE Study Group

    Version of Record online : 16 APR 2015, DOI: 10.1111/cea.12522

  2. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2218–2224, Geert D'Haens, Marc Ferrante, Severine Vermeire, Filip Baert, Maja Noman, Liesbeth Moortgat, Patricia Geens, Doreen Iwens, Isolde Aerden, Gert Van Assche, Gust Van Olmen and Paul Rutgeerts

    Version of Record online : 16 FEB 2012, DOI: 10.1002/ibd.22917

  3. You have free access to this content
    Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis

    Journal of Internal Medicine

    Volume 270, Issue 1, July 2011, Pages: 50–57, K. Andréasson, A. Scheja, T. Saxne, B. Ohlsson and R. Hesselstrand

    Version of Record online : 9 JAN 2011, DOI: 10.1111/j.1365-2796.2010.02340.x

  4. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control

    Inflammatory Bowel Diseases

    Volume 18, Issue 11, November 2012, Pages: 2018–2025, Patrick F. van Rheenen

    Version of Record online : 24 JAN 2012, DOI: 10.1002/ibd.22896

  5. Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 7, July 2014, Pages: 1406–1412, Keisuke Inoue, Tomoki Aomatsu, Atsushi Yoden, Takeru Okuhira, Emiri Kaji and Hiroshi Tamai

    Version of Record online : 15 JUL 2014, DOI: 10.1111/jgh.12578

  6. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

    Inflammatory Bowel Diseases

    Volume 15, Issue 8, August 2009, Pages: 1190–1198, Javier P. Gisbert, Fernando Bermejo, Jose-Lázaro Pérez-Calle, Carlos Taxonera, Isabel Vera, Adrian G. McNicholl, Alicia Algaba, Pilar López, Natalia López-Palacios, Marta Calvo, Yago González-Lama, Jose-Antonio Carneros, Marta Velasco and José Maté

    Version of Record online : 16 MAR 2009, DOI: 10.1002/ibd.20933

  7. Calprotectin Induces IL-6 and MCP-1 Production via Toll-Like Receptor 4 Signaling in Human Gingival Fibroblasts

    Journal of Cellular Physiology

    Volume 232, Issue 7, July 2017, Pages: 1862–1871, Yasufumi Nishikawa, Yukari Kajiura, Jung Hwan Lew, Jun-ichi Kido, Toshihiko Nagata and Koji Naruishi

    Version of Record online : 6 JAN 2017, DOI: 10.1002/jcp.25724

  8. You have free access to this content
    Emerging role of calprotectin in gastroenterology

    Journal of Gastroenterology and Hepatology

    Volume 18, Issue 7, July 2003, Pages: 756–762, ANDREW POULLIS, RUSSELL FOSTER, MICHAEL A MENDALL and MAGNE K FAGERHOL

    Version of Record online : 10 JUN 2003, DOI: 10.1046/j.1440-1746.2003.03014.x

  9. Ulcerative colitis: Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes

    Inflammatory Bowel Diseases

    Volume 15, Issue 12, December 2009, Pages: 1851–1858, Alain M. Schoepfer, Christoph Beglinger, Alex Straumann, Michael Trummler, Pietro Renzulli and Frank Seibold

    Version of Record online : 21 MAY 2009, DOI: 10.1002/ibd.20986

  10. Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 15, Issue 5, May 2009, Pages: 756–759, Michael A. Quail, Richard K. Russell, Johan E. Van Limbergen, Pam Rogers, Hazel E. Drummond, David C. Wilson and Peter M. Gillett

    Version of Record online : 23 DEC 2008, DOI: 10.1002/ibd.20820

  11. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis

    Liver International

    Volume 31, Issue 9, October 2011, Pages: 1406–1415, Felix Gundling, Fabian Schmidtler, Alexander Hapfelmeier, Benjamin Schulte, Thomas Schmidt, Christian Pehl, Wolfgang Schepp and Holger Seidl

    Version of Record online : 6 SEP 2011, DOI: 10.1111/j.1478-3231.2011.02577.x

  12. Faecal calprotectin concentrations in children with functional gastrointestinal disorders diagnosed according to the Pediatric Rome III criteria

    Acta Paediatrica

    Volume 99, Issue 5, May 2010, Pages: 734–737, G Flagstad, H Helgeland and T Markestad

    Version of Record online : 5 MAR 2010, DOI: 10.1111/j.1651-2227.2010.01698.x

  13. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

    Inflammatory Bowel Diseases

    Volume 14, Issue 3, March 2008, Pages: 359–366, Marc A. Sidler, Steven T. Leach and Andrew S. Day

    Version of Record online : 29 NOV 2007, DOI: 10.1002/ibd.20336

  14. The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 5, September 2016, Pages: 495–504, Y. Zhulina, Y. Cao, K. Amcoff, M. Carlson, C. Tysk and J. Halfvarson

    Version of Record online : 12 JUL 2016, DOI: 10.1111/apt.13731

  15. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children

    Acta Paediatrica

    Volume 91, Issue 1, January 2002, Pages: 45–50, E Olafsdottir, L Aksnes, G Fluge and A Berstad

    Version of Record online : 2 JAN 2007, DOI: 10.1111/j.1651-2227.2002.tb01638.x

  16. Calprotectin levels in meconium

    Acta Paediatrica

    Volume 92, Issue 4, April 2003, Pages: 463–466, N Laforgia, ME Baldassarre, G Pontrelli, F Indrio, MA Altomare, G Di Bitonto and A Mautone

    Version of Record online : 2 JAN 2007, DOI: 10.1111/j.1651-2227.2003.tb00579.x

  17. Plasma Calprotectin Predicts Mortality in Patients with ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

    Journal of Interventional Cardiology


    Version of Record online : 12 MAR 2010, DOI: 10.1111/j.1540-8183.2010.00532.x

  18. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings

    Inflammatory Bowel Diseases

    Volume 14, Issue 1, January 2008, Pages: 40–46, Taina Sipponen, Erkki Savilahti, Kaija-Leena Kolho, Hannu Nuutinen, Ulla Turunen and Martti Färkkilä

    Version of Record online : 16 NOV 2007, DOI: 10.1002/ibd.20312

  19. Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 8, August 2012, Pages: 1493–1497, Ron Shaoul, Marlgozata Sladek, Dan Turner, Anders Paeregaard, Gabor Veres, Gigi Veereman Wauters, Johanna Escher, Jorge Amil Dias, Paolo Lionetti, Annamaria Staino, Kaija Leena Kolho, Lissy de Ridder, Federica Nuti, Salvatore Cucchiara, Orit Sheva, Arie Levine and and the ESPGHAN Porto IBD Group

    Version of Record online : 24 JAN 2012, DOI: 10.1002/ibd.21875

  20. Fecal calprotectin mirrors inflammation of the distal ileum and bowel function after restorative proctocolectomy for pediatric-onset ulcerative colitis

    Inflammatory Bowel Diseases

    Volume 16, Issue 3, March 2010, Pages: 482–486, Mikko P. Pakarinen, Antti Koivusalo, Johanna Natunen, Merja Ashorn, Riitta Karikoski, Petri Aitola, Risto J. Rintala and Kaija-Leena Kolho

    Version of Record online : 14 AUG 2009, DOI: 10.1002/ibd.21069